Fagron

Contact, telefoonnummer, adres & vestigingen.

From local player to global market leader and consolidator in the market of pharmaceutical compounding in only 20 years.

Fagron was founded in Rotterdam (the Netherlands) in 1990 by Ger van Jeveren, the current CEO of the Fagron Group. Through a continuous focus on innovation, quality and solution-oriented thinking, Ger van Jeveren brought market leadership in pharmaceutical compounding to Fagron in the Netherlands in just 7 years.
Ger van Jeveren continued to direct further development and international growth, with the result that Fagron is currently the global market leader and active in 30 countries in Europe, the Americas, the Middle East, Africa, Asia, and the Pacific. Fagron products are sold to 200,000 customers in over 60 countries around the world.
Over 200 Fagron pharmacists are continually developing new, unique products and concepts to meet the growing worldwide need for tailor-made medication.

Market leadership provides major competitive advantages, such as the central procurement of raw materials, optimal utilisation of production facilities, and the international roll-out of successful and innovative products and concepts. With over 1,800 employees, Fagron generated a turnover of 335 million in 2013.
Fagron intends to further reinforce its worldwide market leadership based on an active buy-and-build strategy, starting up greenfields and robust organic growth.

Fagron mission and strategy
Fagrons strategy is focused on the optimisation and innovation of pharmaceutical compounding.
As a RD scientific pharmaceutical compounding company, Fagron wants to widen the therapeutic scope of the prescriber to enable tailor-made pharmaceutical care. Through its activities, Fagron supports the unique selling point of the pharmacist and improves the patients quality of life.